Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Mar-19 5:10 PM View:  | Aldeyra Therapeutics, Inc. (ALDX) | 26-Mar-19 | Market Sale | 96,743 | $10.01 | $968,397.00 | (5%) 1.98M to 1.89M | 25% |
| 04-Mar-19 6:03 PM View: | Veracyte, Inc. (VCYT) | 04-Mar-19 | Market Sale | 427,151 | $20.21 | $8,632,720.00 | (26%) 1.66M to 1.23M | (176%) |
| 04-Mar-19 6:03 PM View: | Veracyte, Inc. (VCYT) | 01-Mar-19 | Market Sale | 275,000 | $20.45 | $5,623,750.00 | (14%) 1.94M to 1.66M | (173%) |
| 04-Mar-19 6:03 PM View: | Veracyte, Inc. (VCYT) | 28-Feb-19 | Market Sale | 350,000 | $20.50 | $7,176,400.00 | (15%) 2.29M to 1.94M | (172%) |
| 02-Aug-18 4:11 PM View: | Veracyte, Inc. (VCYT) | 01-Aug-18 | Market Sale | 120,000 | $10.85 | $1,302,000.00 | (5%) 2.41M to 2.29M | (414%) |
| 02-Aug-18 4:11 PM View: | Veracyte, Inc. (VCYT) | 31-Jul-18 | Market Sale | 380,000 | $10.82 | $4,111,600.00 | (14%) 2.79M to 2.41M | (416%) |
| 18-May-17 5:37 PM View: | Veracyte, Inc. (VCYT) | 16-May-17 | Acquisition (other) | 1,642 | -- | -- | < 1% 2.81M to 2.81M | |
| 18-May-17 5:37 PM View: | Veracyte, Inc. (VCYT) | 16-May-17 | Acquisition (other) | 1,641 | -- | -- | < 1% 2.81M to 2.81M | |
| 18-May-17 5:37 PM View: | Veracyte, Inc. (VCYT) | 16-May-17 | Disposition (other) | 25,245 | -- | -- | (< 1%) 2.81M to 2.79M | |
| 18-May-17 5:37 PM View: | Veracyte, Inc. (VCYT) | 16-May-17 | Market Sale | 2,226 | $8.08 | $17,986.10 | (< 1%) 2.79M to 2.79M | (592%) |
| 21-Mar-14 7:43 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition Duplicate | 10,442,500 | $14.00 | $146,195,008.00 | (100%) 10.44M to 0 | < 1% |
| 17-Mar-14 3:00 PM View: | Achaogen, Inc. (AKAO) | 17-Mar-14 | Conversion Duplicate | 2,020,940 | -- | -- | 100% 0 to 2.02M | |
| 04-Feb-14 3:33 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 04-Feb-14 | Conversion Duplicate | 1,765,710 | -- | -- | 100% 0 to 1.77M | |
| 19-Nov-13 6:42 PM View: | Tandem Diabetes Care Inc (TNDM) | 19-Nov-13 | Conversion Duplicate | 3,243,450 | -- | -- | 100% 0 to 3.24M | |
| 04-Nov-13 4:18 PM View: | Veracyte, Inc. (VCYT) | 04-Nov-13 | Conversion Duplicate | 3,086,020 | -- | -- | 100% 0 to 3.09M | |
| 30-Sep-13 5:40 PM View: | Evoke Pharma Inc (EVOK) | 30-Sep-13 | Conversion Duplicate | 1,133,330 | -- | -- | 21587% 5.25K to 1.14M | |
| 28-Aug-13 12:15 PM View: | Tobira Therapeutics, Inc. (TBRA) | 27-Aug-13 | Conversion Duplicate | 1,800,110 | -- | -- | 3390% 53.1K to 1.85M | |
| 28-Aug-13 12:15 PM View: | Tobira Therapeutics, Inc. (TBRA) | 27-Aug-13 | Purchase Duplicate | 750,000 | $4.00 | $3,000,000.00 | 40% 1.85M to 2.6M | |
| 16-Jul-13 8:16 PM View: | Tranzyme, Inc. (OCRX) | 15-Jul-13 | Purchase Duplicate | 1,327,490 | $6.03 | $7,999,990.00 | 81% 1.63M to 2.96M | |
| 02-Jul-13 4:35 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Conversion Duplicate | 1,816,470 | -- | -- | 100% 0 to 1.82M | |
| 02-Jul-13 4:35 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Purchase Duplicate | 285,714 | $14.00 | $4,000,000.00 | 16% 1.82M to 2.1M | |
| 18-Jan-13 12:38 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 18-Jan-13 | Acquisition (other) Duplicate | 66,462 | -- | -- | < 1% 6.95M to 7.02M | |
| 18-Jan-13 12:38 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 18-Jan-13 | Disposition (other) Duplicate | 1,000,000 | -- | -- | (14%) 7.02M to 6.02M | |
| 24-Jul-12 12:01 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion Duplicate | 2,244,120 | -- | -- | 100% 0 to 2.24M | |
| 24-Jul-12 12:01 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 784,313 | $9.00 | $7,058,820.00 | 35% 2.24M to 3.03M | |
| 04-Jun-12 2:58 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 31-May-12 | Acquisition (other) Duplicate | 93,434 | -- | -- | 1% 8.06M to 8.15M | |
| 04-Jun-12 2:58 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 31-May-12 | Disposition (other) Duplicate | 1,200,000 | -- | -- | (15%) 8.15M to 6.95M | |
| 27-Mar-12 3:34 PM View: | Reva Medical, Inc. (RVA.AX) | 23-Mar-12 | Sale Duplicate | 1,695,720 | $5.16 | $8,749,900.00 | (31%) 5.39M to 3.69M | |
| 22-Dec-11 5:33 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 22-Dec-11 | Private Purchase Duplicate | 469,147 | $1.45 | $680,263.00 | 18% 2.55M to 3.02M | |
| 21-Nov-11 8:59 PM View: | Clovis Oncology, Inc. (CLVS) | 21-Nov-11 | Conversion Duplicate | 2,110,270 | -- | -- | 100% 0 to 2.11M | |
| 21-Nov-11 8:59 PM View: | Clovis Oncology, Inc. (CLVS) | 21-Nov-11 | Market Purchase Duplicate | 931,683 | $13.00 | $12,111,900.00 | 44% 2.11M to 3.04M | (62%) |
| 20-Sep-11 3:02 PM View: | Zogenix, Inc. (ZGNX) | 16-Sep-11 | Market Purchase Duplicate | 3,500,000 | $2.00 | $7,000,000.00 | 53% 6.59M to 10.09M | 33% |
| 03-Jun-11 1:38 PM View: | Alimera Sciences Inc (ALIM) | 02-Jun-11 | Acquisition (other) Duplicate | 18,864 | -- | -- | < 1% 4.88M to 4.9M | |
| 03-Jun-11 1:38 PM View: | Alimera Sciences Inc (ALIM) | 02-Jun-11 | Disposition (other) Duplicate | 700,000 | -- | -- | (14%) 4.9M to 4.2M | |
| 03-Jun-11 1:38 PM View: | Alimera Sciences Inc (ALIM) | 02-Jun-11 | Market Sale Duplicate | 6,914 | $8.04 | $55,588.60 | (< 1%) 4.2M to 4.19M | 96% |
| 20-Dec-10 9:43 PM View: | Reva Medical, Inc. (RVA.AX) | 16-Dec-10 | Conversion Duplicate | 3,188,450 | -- | -- | 100% 0 to 3.19M | |
| 20-Dec-10 9:43 PM View: | Reva Medical, Inc. (RVA.AX) | 16-Dec-10 | Acquisition (other) Duplicate | 127,487 | $6.51 | $829,501.00 | 4% 3.19M to 3.32M | |
| 20-Dec-10 9:43 PM View: | Reva Medical, Inc. (RVA.AX) | 16-Dec-10 | Exercise (in-the money or at-the-money) Duplicate | 2,070,960 | $3.36 | $6,959,110.00 | 62% 3.32M to 5.39M | |
| 01-Dec-10 10:19 AM View: | Zogenix, Inc. (ZGNX) | 29-Nov-10 | Conversion Duplicate | 4,252,590 | -- | -- | 100% 0 to 4.25M | |
| 01-Dec-10 10:19 AM View: | Zogenix, Inc. (ZGNX) | 29-Nov-10 | Purchase Duplicate | 2,350,000 | $4.00 | $9,400,000.00 | 55% 4.25M to 6.6M | |
| 08-Oct-10 4:55 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 06-Oct-10 | Acquisition (other) Duplicate | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 11-Jun-10 12:59 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 09-Jun-10 | Disposition | 53,689 | -- | -- | (100%) 53.69K to 0 | |
| 27-Apr-10 5:21 PM View: | Alimera Sciences Inc (ALIM) | 27-Apr-10 | Conversion Duplicate | 4,499,450 | -- | -- | 100% 0 to 4.5M | |
| 27-Apr-10 5:21 PM View: | Alimera Sciences Inc (ALIM) | 27-Apr-10 | Purchase Duplicate | 378,028 | $11.00 | $4,158,310.00 | 8% 4.5M to 4.88M | |
| 02-Apr-10 6:18 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Mar-10 | Grant | 1,371 | -- | -- | 3% 52.32K to 53.69K | |
| 04-Jan-10 12:14 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 31-Dec-09 | Grant | 9,144 | -- | -- | 21% 43.17K to 52.32K | |
| 18-Dec-09 7:48 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 18-Dec-09 | Market Sale | 80,474 | $1.10 | $88,521.40 | (100%) 80.47K to 0 | 82% |
| 21-Dec-09 9:36 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 18-Dec-09 | Market Purchase Duplicate | 38,100 | $7.50 | $285,750.00 | 2% 2.51M to 2.55M | (96%) |
| 18-Dec-09 7:48 PM View: | Somaxon Pharmaceuticals, Inc. (SOMX) | 17-Dec-09 | Market Sale | 816,292 | $1.04 | $848,944.00 | (91%) 896.77K to 80.47K | 81% |
| 21-Dec-09 9:36 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 17-Dec-09 | Market Purchase Duplicate | 100,000 | $7.55 | $755,000.00 | 4% 2.41M to 2.51M | (96%) |